A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Marvin J. Stone, Edward A. Sausville, Joseph W. Fay, Donna Headlee, Robert H. Collins, William D. Figg, Maryalice Stetler-Stevenson, Vinay Jain, Elaine S. Jaffe, Diane Solomon, Richard M. Lush, Adrian Senderowicz, Victor Ghetie, John Schindler, Jonathan W. Uhr, Ellen S. Vitetta